Journal of Pediatric Gastroenterology and Nutrition · 2010 · 51 citations · 14 references
MedicinePediatricsPharmacotherapyPediatric Clinical PharmacologyPediatric GastroenterologyPediatric TherapeuticsPediatric Gastrointestinal DisordersPediatric Intestinal DisordersIntestinal LymphangiectasiaOctreotide TherapyPediatric CasesSafety Profile CharacterizationSerum Albumin MonitoringSerum Albumin UseSide Effect ProfileStool Frequency Assessment
OBJECTIVE: Octreotide has been suggested as a medical treatment option in refractory cases of primary intestinal lymphangiectasia (IL). There are few data about the long-term effect and safety of octreotide for IL in the literature. In the present article we analyzed pediatric cases of primary IL with long-term octreotide treatment and discussed its safety profile. METHODS: Between 1999 and 2008, 13 children were diagnosed in our clinic as having IL. Six patients with primary IL were followed up, receiving octreotide therapy. The clinical data of the patients and duration of therapy, dose, and side effects of octreotide were evaluated. RESULTS: Octreotide, 15 to 20 μg per body weight 2 times daily subcutaneously, was given to all of the patients. Duration of the octreotide treatment changed between 3 and 37 months. Stool frequency decreased in all of the patients after starting octreotide treatment. Serum albumin could be maintained at normal levels in 3 patients. The requirement of albumin infusions decreased in all of the patients. Acute pancreatitis was observed as a side effect of octreotide in 1 patient. CONCLUSIONS: Octreotide may help to maintain serum albumin levels, improve clinical findings, and decrease the requirement of albumin infusions in refractory cases of primary IL.
14
Chirag Trivedi, C. S. Pitchumoni · Journal of Clinical Gastroenterology · 2005 · 367 citations
Pediatric gastrointestinal disease
Martin H. Ulshen · Gastroenterology · 2005 · 293 citations
Octreotide in the Treatment of Thoracic Duct Injuries
Kevin M. Markham, John L. Glover, Robert Welsh et al. · The American Surgeon · 2000 · 138 citations
Conservative Treatment of Postsurgical Lymphatic Leaks With Somatostatin-14
Jean-Marie Collard, Pierre‐François Laterre, F Boemer et al. · CHEST Journal · 2000 · 131 citations